My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 172

    1.

    Failure to develop HIV infection after receipt of HIV-contaminated blood and postexposure prophylaxis.

    Katzenstein TL, Dickmeiss E, Aladdin H, Hede A, Nielsen C, Nielsen H, Jørgensen LB, Gerstoft J.

    Ann Intern Med. 2000 Jul 4;133(1):31-4. No abstract available. PMID: 10877737 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Tolerability of postexposure prophylaxis with zidovudine, lamivudine, and nelfinavir for human immunodeficiency virus infection.

    Rabaud C, Bevilacqua S, Beguinot I, Dorvaux V, Schuhmacher H, May T, Canton P.

    Clin Infect Dis. 2001 May 15;32(10):1494-5. Epub 2001 Apr 18.PMID: 11317252 [PubMed - indexed for MEDLINE]Related articles

    3.

    Report updates recommendations for health workers exposed to HIV.

    [No authors listed]

    Am J Health Syst Pharm. 1998 Sep 1;55(17):1755. No abstract available. PMID: 9867409 [PubMed - indexed for MEDLINE]Related articles

    4.

    Summaries for patients. Predictors of outcomes in patients with HIV infection treated with indinavir, zidovudine, and lamivudine.

    [No authors listed]

    Ann Intern Med. 2001 Dec 4;135(11):S-59. No abstract available. PMID: 11759663 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    HIV postexposure prophylaxis: new recommendations.

    Patrick DM.

    CMAJ. 1997 Jan 15;156(2):233-4. English, French. No abstract available. PMID: 9012728 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    AVANTI 3: a randomized, double-blind trial to compare the efficacy and safety of lamivudine plus zidovudine versus lamivudine plus zidovudine plus nelfinavir in HIV-1-infected antiretroviral-naive patients.

    Gartland M; AVANTI Study Group.

    Antivir Ther. 2001 Jun;6(2):127-34.PMID: 11491417 [PubMed - indexed for MEDLINE]Related articles

    7.

    Chemoprophylaxis after occupational exposure to human immunodeficiency virus in forensic autopsy.

    Kibayashi K, NG'walali PM, Tsunenari S.

    Nihon Hoigaku Zasshi. 1998 Apr;52(2):163-4. No abstract available. PMID: 9711070 [PubMed - indexed for MEDLINE]Related articles

    8.

    [Prophylactic antiretroviral therapy after sexual exposure to HIV: 93 cases]

    Timsit FJ, Maillard A, Spindler E, Taquin Y, Deniaud F, Ferchal F, Morel P, Janier M.

    Ann Dermatol Venereol. 2002 Jun-Jul;129(6-7):866-9. French. PMID: 12218913 [PubMed - indexed for MEDLINE]Related articles

    9.

    Failure of postexposure prophylaxis after sexual exposure to HIV.

    Fournier S, Maillard A, Molina JM.

    AIDS. 2001 Feb 16;15(3):430. No abstract available. PMID: 11273232 [PubMed - indexed for MEDLINE]Related articles

    10.

    Hypercholesterolemia in a health care worker receiving thyroxine after postexposure prophylaxis for human immunodeficiency virus infection.

    Nerad JL, Kessler HA.

    Clin Infect Dis. 2001 Jun 1;32(11):1635-6. Epub 2001 Apr 30.PMID: 11340537 [PubMed - indexed for MEDLINE]Related articles

    11.

    Effect of zidovudine resistance mutations on virologic response to treatment with zidovudine or stavudine, each in combination with lamivudine and indinavir.

    Descamps D, Flandre P, Joly V, Meiffrédy V, Peytavin G, Izopet J, Tamalet C, Zeng AF, Harel M, Lastère S, Aboulker JP, Yéni P, Brun-Vézinet F; NOVAVIR (ANRS 073) Study Group.

    J Acquir Immune Defic Syndr. 2002 Dec 15;31(5):464-71. Erratum in: J Acquir Immune Defic Syndr. 2003 Jan;32(1):116.. PMID: 12473833 [PubMed - indexed for MEDLINE]Related articles

    12.

    Transmission of drug-resistant HIV after an occupational exposure despite postexposure prophylaxis with a combination drug regimen.

    Beltrami EM, Luo CC, de la Torre N, Cardo DM.

    Infect Control Hosp Epidemiol. 2002 Jun;23(6):345-8.PMID: 12083242 [PubMed - indexed for MEDLINE]Related articles

    13.

    Comparative studies of two-times-daily versus three-times-daily indinavir in combination with zidovudine and lamivudine.

    Haas DW, Arathoon E, Thompson MA, de Jesus Pedro R, Gallant JE, Uip DE, Currier J, Noriega LM, Lewi DS, Uribe P, Benetucci L, Cahn P, Paar D, White AC Jr, Collier AC, Ramirez-Ronda CH, Harvey C, Chung MO, Mehrotra D, Chodakewitz J, Nguyen BY; Protocol 054/069 Study Teams.

    AIDS. 2000 Sep 8;14(13):1973-8.PMID: 10997402 [PubMed - indexed for MEDLINE]Related articles

    14.

    Predictors of virologic and clinical outcomes in HIV-1-infected patients receiving concurrent treatment with indinavir, zidovudine, and lamivudine. AIDS Clinical Trials Group Protocol 320.

    Demeter LM, Hughes MD, Coombs RW, Jackson JB, Grimes JM, Bosch RJ, Fiscus SA, Spector SA, Squires KE, Fischl MA, Hammer SM.

    Ann Intern Med. 2001 Dec 4;135(11):954-64.PMID: 11730396 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Efficacy of zidovudine compared to stavudine, both in combination with lamivudine and indinavir, in human immunodeficiency virus-infected nucleoside-experienced patients with no prior exposure to lamivudine, stavudine, or protease inhibitors (novavir trial).

    Joly V, Flandre P, Meiffredy V, Brun-Vezinet F, Gastaut JA, Goujard C, Remy G, Descamps D, Ruffault A, Certain A, Aboulker JP, Yeni P; Novavir Study Group.

    Antimicrob Agents Chemother. 2002 Jun;46(6):1906-13.PMID: 12019107 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    HIV postexposure prophylaxis after sexual assault: why is it so hard to accomplish?

    Cohen MS.

    Sex Transm Dis. 2008 Dec;35(12):979-80. No abstract available. PMID: 18955917 [PubMed - indexed for MEDLINE]Related articles

    17.

    Needle-stick injuries and HIV infection: a surgeon's personal experience and review of postexposure prophylaxis. St. Paul's Ocular AIDS Group.

    Hurwitz JJ, Fine N, Rachlis AR.

    Can J Ophthalmol. 1999 Jun;34(4):195-203. No abstract available. PMID: 10396655 [PubMed - indexed for MEDLINE]Related articles

    18.

    Adherence to antiretroviral therapy and outcomes in HIV-infected patients enrolled in an induction/maintenance randomized trial.

    Flandre P, Peytavin G, Meiffredy V, Saidi Y, Descamps D, Delagnes M, Brun-Vézinet F, Raffi F; Trilège (Agence Nationale de Recherches sur le SIDA 072) Study Team.

    Antivir Ther. 2002 Jun;7(2):113-21.PMID: 12212923 [PubMed - indexed for MEDLINE]Related articles

    19.

    3-year suppression of HIV viremia with indinavir, zidovudine, and lamivudine.

    Gulick RM, Mellors JW, Havlir D, Eron JJ, Meibohm A, Condra JH, Valentine FT, McMahon D, Gonzalez C, Jonas L, Emini EA, Chodakewitz JA, Isaacs R, Richman DD.

    Ann Intern Med. 2000 Jul 4;133(1):35-9.PMID: 10877738 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Prevalence and predictive value of intermittent viremia with combination hiv therapy.

    Havlir DV, Bassett R, Levitan D, Gilbert P, Tebas P, Collier AC, Hirsch MS, Ignacio C, Condra J, Günthard HF, Richman DD, Wong JK.

    JAMA. 2001 Jul 11;286(2):171-9.PMID: 11448280 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is temporarily unavailable.

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    » See more...